Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The aim of the current study is to evaluate the safety and efficay of cilostazol in treatment
of patients with fatty liver disease. Several previous reports have shown that cilostazol
ameliorates lipid imbalances in NAFLD. Cilostazol appeared to exert beneficial effects
against NAFLD